-
-
08 May 2017
-
-
-
20 Jan 2017
Nemus Bioscience Announces Licensing Agreement with the University of Mississippi
COSTA MESA, CA / ACCESSWIRE / January 11, 2017 / NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that the company had signed a licensing agreement with the University of Mississippi (UM) for a platform of cannabinoid-based molecules (UM5070) for potential anti-infective use against bacteria, viruses, and fungi. The agreement culminates roughly one year of screening and target molecule identification studies especially focused on therapy-resistant infectious organisms like methicillin-resistant Staphylococcus aureus (MRSA). Read more →
-
-
-
17 Jun 2016
-
-
-
14 Apr 2016
-
-
-
29 Feb 2016
-
-
-
09 Feb 2016
Students Create Wardrobe-sharing Platform: Nimble
OXFORD, Miss. (The Daily Mississippian, February 9, 2016) - Last year saw the rise of apps and services such as Airbnb and Uber. The format of peer-to-peer sharing services is more popular than ever, and now an Oxford startup company is adopting a similar format for their most recent app, Nimble Fashion. Read more →
-
-
-
08 Jan 2016
NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development
The prodrug of THC has previously been shown in University of Mississippi experiments to successfully enter multiple chambers of the eye when administered to animals by topical drop and bioerodable film. Additionally, in experiments conducted at the University of Mississippi, it has been reported that NB1111 topical drops successfully lowered IOP in the α-chymotrypsin induced rabbit glaucoma model by 45% - 50%. That study also showed that dosing of the topical drop would require more than five applications a day to insure IOP coverage. Read more → -
-
-
08 Jan 2016
-
-
-
23 Nov 2015
-
-
-
10 Nov 2015
-
